Michael Halpin
Chief Operating Officer at VERICEL CORPORATION
Net worth: 49 367 $ as of 2024-03-30
Profile
Michael Halpin is currently the Chief Operating Officer at Vericel Corp.
Prior to his current position, he held the role of Vice President-North American Region Regulatory at Genzyme Corp.
from 2002 to 2017.
He also worked as Vice President-North American Region Regulatory at Sanofi Corp.
Mr. Halpin completed his undergraduate and graduate degrees at the University of Virginia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERICEL CORPORATION
0.00% | 2024-03-10 | 949 ( 0.00% ) | 49 367 $ | 2024-03-30 |
Michael Halpin active positions
| Companies | Position | Start |
|---|---|---|
| VERICEL CORPORATION | Chief Operating Officer | 2019-06-14 |
Former positions of Michael Halpin
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | - |
| Sanofi Corp. | Corporate Officer/Principal | - |
Training of Michael Halpin
| University of Virginia | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Sanofi Corp. |
- Stock Market
- Insiders
- Michael Halpin
